CYCLERION THERAPEUTICS, INC. Gain on Business Interruption Insurance Recovery
CYCLERION THERAPEUTICS, INC. (CYCN) reported Gain on Business Interruption Insurance Recovery of $1.32 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-07-22.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainOnBusinessInterruptionInsuranceRecovery · last filed 2026-08-04
- CYCLERION THERAPEUTICS, INC. gain on business interruption insurance recovery for the quarter ending 2025-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. gain on business interruption insurance recovery for the quarter ending 2025-09-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. gain on business interruption insurance recovery for the quarter ending 2025-06-30 was $1.32M.
- CYCLERION THERAPEUTICS, INC. gain on business interruption insurance recovery for the quarter ending 2024-12-31 was $0.00.
| Period end | Gain on Business Interruption Insurance Recovery 3 month | Gain on Business Interruption Insurance Recovery 6 month | Gain on Business Interruption Insurance Recovery 9 month | Gain on Business Interruption Insurance Recovery 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $0.00 derived: sum of 2 quarters · filed 2026-07-22 | $1.32M derived: sum of 3 quarters · filed 2026-08-04 | $1.32M S-4/A · filed 2026-07-22 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $1.32M derived: sum of 2 quarters · filed 2026-08-04 | $1.32M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.32M 10-Q · filed 2026-08-04 | $1.32M 10-Q · filed 2026-08-04 | ||
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $0.00 derived: sum of 2 quarters · filed 2026-07-22 | $0.00 derived: sum of 3 quarters · filed 2026-07-22 | $0.00 S-4/A · filed 2026-07-22 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |